Literature DB >> 34786021

Diabetic ketoacidosis, COVID-19 and blood viscosity.

Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Keywords:  Blood; COVID-19; Diabetes; Ketoacidosis; Viscosity

Year:  2021        PMID: 34786021      PMCID: PMC8582116          DOI: 10.1016/j.jtumed.2021.10.003

Source DB:  PubMed          Journal:  J Taibah Univ Med Sci        ISSN: 1658-3612


× No keyword cloud information.
Dear Editor, we would like to share ideas on the publication “Diabetic ketoacidosis precipitated by atypical coronavirus disease in a newly diagnosed diabetic girl”. Albuali and AlGhamdi reported an interesting case and concluded that “We conclude that SARS-CoV-2 may trigger the onset of T1DM and may precipitate the occurrence of DKA in paediatric diabetic patients, even in the absence of respiratory symptoms”. Ketoacidosis is an important endocrine problem that might occur in a patient with COVID-19. Affected cases might have diabetes type 1 or 2. The problem is also observable in cases where blood glucose is not that high (<300 mg/dL). Regarding the pathomechanism, according to a publication by Vitale et al., a direct toxic effect of the SASR CoV2 on the pancreatic islets or accelerated inflammatory response is proposed as promoting ketosis. However, as seen in the present case, an overt inflammatory parameter is usually not seen, and it might not explain occurrence in a case with euglycemic status. Another possible pathological process that should be mentioned is hyperviscosity induced by COVID-19. In COVID-19, a high blood viscosity can occur, and hyperviscosity can further induce ketoacidosis.,

Source of funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of interest

The authors have no conflict of interest to declare.

Ethical approval

The authors confirm that this letter has been conducted in accordance with COPE rules and regulations. Given the nature of the letter, the IRB review was not required.

Authors contributions

Both authors have contributed equally and met all four of the following criteria: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work AND drafting the work or revising it critically for important intellectual content AND final approval of the version to be published AND agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All authors have critically reviewed and approved the final draft and are responsible for the content and similarity index of the manuscript.
  6 in total

1.  Blood viscosity of COVID-19 patient: a preliminary report.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Am J Blood Res       Date:  2021-02-15

2.  Stroke as the presenting feature of new onset diabetes in a young man.

Authors:  Ruth Jones; Emily McMurray; Oliver Robinson
Journal:  BMJ Case Rep       Date:  2014-06-25

3.  Clinical use of the anion gap.

Authors:  M Emmett; R G Narins
Journal:  Medicine (Baltimore)       Date:  1977-01       Impact factor: 1.889

4.  COVID-19 Presenting With Diabetic Ketoacidosis: A Case Series.

Authors:  Ramya S Gorthi; Ghassan Kamel; Sandeep Dhindsa; Ravi P Nayak
Journal:  AACE Clin Case Rep       Date:  2020-12-28

5.  Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.

Authors:  Rebecca J Vitale; Yannis K Valtis; Marie E McDonnell; Nadine E Palermo; Naomi D L Fisher
Journal:  AACE Clin Case Rep       Date:  2020-12-28

6.  Diabetic ketoacidosis precipitated by atypical coronavirus disease in a newly diagnosed diabetic girl.

Authors:  Waleed H Albuali; Nora A AlGhamdi
Journal:  J Taibah Univ Med Sci       Date:  2021-02-16
  6 in total
  2 in total

1.  Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  J Clin Res Pediatr Endocrinol       Date:  2022-05-31

2.  In response to: "Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic".

Authors:  Emine Ayça Cimbek; Gülay Kaya; Osman Yeşilbaş; Gülay Karagüzel
Journal:  J Clin Res Pediatr Endocrinol       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.